Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei.
A non-targeted metabolomics-based approach is presented that enables the study of pathways in response to drug action with the aim of defining the mode of action of trypanocides. Eflornithine, a polyamine pathway inhibitor, and nifurtimox, whose mode of action involves its metabolic activation, are...
Guardado en:
Autores principales: | Isabel M Vincent, Darren J Creek, Karl Burgess, Debra J Woods, Richard J S Burchmore, Michael P Barrett |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/83e3c421bbaa428ebc5866edd98e7162 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A molecular mechanism for eflornithine resistance in African trypanosomes.
por: Isabel M Vincent, et al.
Publicado: (2010) -
Genetic control of resistance to Trypanosoma brucei brucei infection in mice.
por: Matyáš Síma, et al.
Publicado: (2011) -
Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.
por: Andrea Kuemmerle, et al.
Publicado: (2021) -
Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study
por: Andrea Kuemmerle, et al.
Publicado: (2021) -
Enantiospecific antitrypanosomal in vitro activity of eflornithine.
por: Mikael Boberg, et al.
Publicado: (2021)